POLARIS (Personalized OMIC Lattice for Advanced Research and Improving Stratification) was established by A*STAR in 2013 to pilot the application of clinical genomics in the treatment and diagnosis of medical diseases in Singapore and the region. CAP-accredited laboratories for Next Generation Sequencing were established, allowing patients with better access to a new generation of clinical care based on precision medicine.
In partnership with the hospitals and local researchers, we have developed and launched tests which can provide specific actionable information to patients and doctors. For example, our eye test is able to advice if a patient contemplating corneal surgery should avoid the procedure as there could be a high risk of complications due to their genetic background. Another test is targeted at patients with certain leukemia or colon cancers, to identify if a particular type of drug would be more effective for their treatment.